State-of-the-Art Technology Revolutionizes Ultrasound-Guided Interventional Tool Guidance

Now, a state-of-the-art ultrasound-guided needle technology ushering in a new era of precision and safety is poised to reshape and revolutionize the future of interventional procedures.

DeepSight Technology’s (Santa Clara, CA, USA) proprietary NeedleVue solution combines innovative sensor technology with most interventional devices, enabling real-time verification of placement and reducing procedural guesswork significantly. Conventional technologies generally pose challenges like laborious calibration processes, lower sensitivity, and the need for precise angles of incidence. NeedleVue delivers across-the-board improvement using its omnidirectional functionality at any plausible ultrasound depth, improving functionality and ease of use in a true "plug-and-play" solution.

DeepSight's NeedleVue delineates a clear paradigm shift in needle guidance technology by delivering real-time, precision needle tracking that is portable as well as easy to use. The groundbreaking technology enhances the ability of clinicians to localize a surgical device during freehand procedures. The resulting improvement in tissue biopsy and therapeutic success leads to a reduction in patient complications, thereby creating better health outcomes. The technology comes as a breath of fresh air at a time when healthcare providers are focused on combining operational efficacy with improved patient outcomes.

"NeedleVue not only signifies a monumental leap in the evolution of interventional tool guidance but also substantiates our steadfast commitment to ensuring procedural success - benefiting patients, clinicians, and healthcare providers alike,” said Nader Sadrzadeh, the Chief Executive Officer at DeepSight Technology. “In a reality where procedural confidence is paramount, our solution stands out as a beacon of precision and reliability, effortlessly aligning with the multifaceted demands of modern healthcare."

Related Links:
DeepSight Technology